Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

HRS.15 Sessions to Attend


Published on

Top 6 Late-Breaking Sessions to Attend at HRS.15

Published in: Education
  • Be the first to comment

  • Be the first to like this

HRS.15 Sessions to Attend

  1. 1. Top 6 Late-Breaking Sessions to Attend at HRS.15 Heart Rhythm Society Scientific Sessions Wednesday, May 13 — Saturday, May 16, 2015 Boston, Massachusetts
  2. 2. (1) Thursday, May 14 1:30–1:45 pm, Ballroom West Impact of Remote Monitoring on Clinical Events & Healthcare Utilization: A Nationwide Assessment Jonathan P. Piccini, MD Duke University Medical Center Durham, N.C.
  3. 3. (2) Thursday, May 14 1:45–2:00 pm, Ballroom West VENTURE-AF: A Randomized Global Trial Evaluating Uninterrupted Rivaroxaban & Vitamin K Antagonists in Patients Undergoing Catheter Ablation for Nonvalvular Atrial Fibrillation Andrea Natale, MD Texas Cardiac Arrhythmia Institute Austin, Texas
  4. 4. (3) Thursday, May 14 2:00–2:15 pm, Ballroom West Cryoballoon versus Open Irrigated Radiofrequency Ablation in Patients with Paroxysmal Atrial Fibrillation: The Prospective, Randomized, Controlled, Noninferiority FreezeAF Study Dr. Armin Luik Städtisches Klinikum Karlsruhe Karlsruhe, Germany
  5. 5. (4) Friday, May 15 8:00–8:15 am, Ballroom West Performance of a Miniaturized Transcatheter Pacing System: First in-human Experience Philippe Ritter, MD Hopital Haut-Leveque Pessac, France
  6. 6. (5) Friday, May 15 8:30–8:45 am, Ballroom West Canadian Registry of Cardiac Implantable Electronic Device Outcomes: Phase 1 Riata Lead on Advisory (CREDO) Ratika Parkash, MD Queen Elizabeth II Health Sciences Centre at Dalhousie University Halifax, Nova Scotia
  7. 7. (6) Friday, May 15 9:15–9:30 am, Ballroom West Visually Guided Laser Balloon (VGLB) Pulmonary Vein Isolation for the Treatment of Paroxysmal Atrial Fibrillation (PAF): Results of the Prospective Multicenter Randomized Heartlight Study Vivek Y. Reddy, MD, Mount Sinai School of Medicine, New York, N.Y.